ATOX1 and malignant tumor of neck: Consistently, small molecules targeting Atox1 have been proved to effectively block Cu-trafficking and consequently reduce cell proliferation in lung, leukemia, breast, head, and neck cancer cell lines by elevating cellular ROS levels via Cu accumulation and reducing cellular NADPH and GSH levels.